CZ20011896A3 - Imunogenní prostředek a protilátka - Google Patents

Imunogenní prostředek a protilátka

Info

Publication number
CZ20011896A3
CZ20011896A3 CZ20011896A CZ20011896A CZ20011896A3 CZ 20011896 A3 CZ20011896 A3 CZ 20011896A3 CZ 20011896 A CZ20011896 A CZ 20011896A CZ 20011896 A CZ20011896 A CZ 20011896A CZ 20011896 A3 CZ20011896 A3 CZ 20011896A3
Authority
CZ
Czechia
Prior art keywords
antibody
immunogenic preparation
immunogenic
preparation
Prior art date
Application number
CZ20011896A
Other languages
English (en)
Inventor
Robert Ian Lechler
Nichola Jane Rogers
Anthony Dorling
Original Assignee
Ml Laboratories Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9827921.9A external-priority patent/GB9827921D0/en
Priority claimed from GBGB9925015.1A external-priority patent/GB9925015D0/en
Application filed by Ml Laboratories Plc filed Critical Ml Laboratories Plc
Publication of CZ20011896A3 publication Critical patent/CZ20011896A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CZ20011896A 1998-12-19 1999-12-17 Imunogenní prostředek a protilátka CZ20011896A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9827921.9A GB9827921D0 (en) 1998-12-19 1998-12-19 Immunosuppression
GBGB9925015.1A GB9925015D0 (en) 1999-10-23 1999-10-23 Immunosuppression

Publications (1)

Publication Number Publication Date
CZ20011896A3 true CZ20011896A3 (cs) 2002-01-16

Family

ID=26314866

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011896A CZ20011896A3 (cs) 1998-12-19 1999-12-17 Imunogenní prostředek a protilátka

Country Status (15)

Country Link
US (1) US20060134124A1 (cs)
EP (1) EP1140153A2 (cs)
JP (1) JP2002532115A (cs)
CN (1) CN1189213C (cs)
AU (1) AU776618B2 (cs)
CA (1) CA2353960A1 (cs)
CZ (1) CZ20011896A3 (cs)
HK (1) HK1042040A1 (cs)
HU (1) HUP0104785A2 (cs)
IL (1) IL143562A0 (cs)
NO (1) NO20013020L (cs)
NZ (1) NZ512196A (cs)
PL (1) PL349315A1 (cs)
TR (1) TR200101785T2 (cs)
WO (1) WO2000037102A2 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810127D0 (en) 1998-05-13 1998-07-08 Ml Lab Plc Prevention of surgical adhesions
US7883855B2 (en) 2006-07-21 2011-02-08 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
US7914999B2 (en) 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
WO2009078875A1 (en) * 2007-12-19 2009-06-25 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
KR101417345B1 (ko) * 2012-09-19 2014-07-08 기아자동차주식회사 연료전지 시스템의 제어 방법
SG10201811190SA (en) 2013-12-16 2019-01-30 Us Health Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon
AU2015360502A1 (en) 2014-12-10 2017-06-29 Regents Of The University Of Minnesota Genetically modified cells, tissues, and organs for treating disease
KR20200020966A (ko) * 2015-03-30 2020-02-26 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 면역용 펩티드, 면역용 펩티드의 제조 방법, 그것을 포함하는 면역 질환용 의약 조성물, 및 면역 질환의 치료 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01500515A (ja) * 1986-06-20 1989-02-23 スクリップス　クリニック　アンド　リサーチ　ファウンデーション Ｂ型肝炎ウィルス表面抗原のプレｓ領域のｔ及びｂ細胞エピトープ
US5489533A (en) * 1987-05-04 1996-02-06 Dana Farber Cancer Institute Isolated nucleic acid molecules encoding ICAM-2
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
WO1997011971A1 (en) * 1995-09-28 1997-04-03 Alexion Pharmaceuticals, Inc. Porcine cell interaction proteins
EP0914427B1 (en) * 1996-05-01 2006-03-29 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis

Also Published As

Publication number Publication date
CN1331603A (zh) 2002-01-16
PL349315A1 (en) 2002-07-15
AU776618B2 (en) 2004-09-16
HK1042040A1 (zh) 2002-08-02
CN1189213C (zh) 2005-02-16
IL143562A0 (en) 2002-04-21
WO2000037102A2 (en) 2000-06-29
TR200101785T2 (tr) 2001-10-22
AU1987500A (en) 2000-07-12
CA2353960A1 (en) 2000-06-29
NZ512196A (en) 2004-12-24
JP2002532115A (ja) 2002-10-02
US20060134124A1 (en) 2006-06-22
WO2000037102A3 (en) 2000-09-14
EP1140153A2 (en) 2001-10-10
NO20013020D0 (no) 2001-06-18
NO20013020L (no) 2001-08-17
HUP0104785A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
IL139286A0 (en) Polyol-ifn-beta conjugates, their preparation and use
PL330111A1 (en) Concentyratyed antibody preparation
CZ20011341A3 (cs) Pomocné přípravky a vakciny
PT1818343E (pt) Anticorpos contra a il-12 humana
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
HUP0301076A3 (en) Linezolid-crystal form ii and preparation thereof
GB9927332D0 (en) Novel antibody and uses thereof
GB9806666D0 (en) Antigen preparation and use
HUP0105392A3 (en) Enhanced vaccines
HUP0100192A3 (en) Improved stomach-action molluscicides and preparation thereof
EP1113815A4 (en) IMMUNOGENIC COMPOSITIONS AND USES THEREOF
CZ20011896A3 (cs) Imunogenní prostředek a protilátka
AU6351199A (en) Pectins and the preparation thereof
GB9822714D0 (en) Vaccines
AUPP363498A0 (en) Antigens and their detection
PL328334A1 (en) Preparation and application thereof
GB9825184D0 (en) Antigen
IL143100A0 (en) Contraceptive antibody vaccines
GB9726147D0 (en) Antigens
GB9800760D0 (en) Antigens
GB9702652D0 (en) Conjugates and their preparation
GB9929923D0 (en) Antigen preparations
EP1066051A4 (en) SCIELLIN AND ITS USE
GB9819015D0 (en) Antigens